Chinese vaccine companies advance research and development in strict accordance with science and regulation requirements and engage in international cooperation in strict compliance with international standards and relevant laws and regulations.
Some Chinese vaccines have entered into phase III clinical trial in relevant countries, making smooth progress on the whole and yielding positive effects and some countries have approved the registration and use of Chinese vaccines.
These all serve to show the safety and effectiveness of Chinese vaccines as well as regulatory authority’s observance of international customary practice and laws, he said.
Wang Wenbin added, China has announced that COVID-19 vaccine development and deployment in China, when available, will be made a global public good that helps to ensure vaccine accessibility and affordability in developing countries. We honor our word and are fulfilling our commitment with concrete actions.
At present, Chinese vaccine companies are sparing no effort to advance their vaccine research and development, and several vaccines have entered phase three clinical trials.
The Chinese government has been actively supporting cooperation between Chinese companies and other countries in vaccine research and development.
At the multilateral level, China is in close communication and cooperation with the WHO, Gavi, the Vaccine Alliance. We have joined COVAX as well as the WHO-sponsored Access to COVID-19 Tools (ACT) Accelerator initiative.
Going forward, the Chinese government will continue to work together with the international community to help ensure all countries will have equal access to safe and effective vaccines.
For underdeveloped or some developing countries, we will help with their vaccine accessibility and affordability through such means as aid, the spokesperson added.